HDAC1 and cervical cancer: Sixto-López et al. synthesized the valproic acid N-(20-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) derivative which downregulated HDAC1 following nuclear to cytoplasmic HMGB1 translocation and amplified ROS production in human cervical cancer cells [84].